These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24072826)

  • 1. A comorbid case of multicentric Castleman's disease and pulmonary hyalinising granuloma successfully treated with tocilizumab and corticosteroid.
    Takeuchi N; Arai T; Kitaichi M; Inoue Y
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24072826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hyalinizing granuloma with Castleman's disease.
    Atagi S; Sakatani M; Akira M; Yamamoto S; Ueda E
    Intern Med; 1994 Nov; 33(11):689-91. PubMed ID: 7849383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
    Saiki R; Katayama K; Hirabayashi Y; Oda K; Fujimoto M; Murata T; Nakajima A; Dohi K
    BMC Nephrol; 2021 Jun; 22(1):216. PubMed ID: 34107915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of multicentric Castleman's disease having lung lesion successfully treated with humanized anti-interleukin-6 receptor antibody, tocilizumab.
    Higuchi T; Nakanishi T; Takada K; Matsumoto M; Okada M; Horikoshi H; Suzuki K
    J Korean Med Sci; 2010 Sep; 25(9):1364-7. PubMed ID: 20808682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
    Lee JP; Kim DK; Oh DY; Paik JH; Moon KC; Kim S; Kim YS
    Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
    Matsuyama M; Suzuki T; Tsuboi H; Ito S; Mamura M; Goto D; Matsumoto I; Tsutsumi A; Sumida T
    Intern Med; 2007; 46(11):771-4. PubMed ID: 17541233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentric Castleman's disease associated with IgA vasculitis (Henoch-Schönlein purpura) responding well to tocilizumab: a case report.
    Oshima Y; Hoshino J; Suwabe T; Hayami N; Yamanouchi M; Sekine A; Ueno T; Mizuno H; Yabuuchi J; Imafuku A; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Hayashi N; Fujii T; Ubara Y
    Clin Rheumatol; 2017 Mar; 36(3):729-733. PubMed ID: 28168662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab.
    Furutera N; Fukunaga N; Okita J; Suzuki T; Suenaga Y; Oyama Y; Aoki K; Fukuda A; Nakata T; Uesugi N; Daa T; Hisano S; Shibata H
    CEN Case Rep; 2021 Feb; 10(1):35-41. PubMed ID: 32715375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evans syndrome complicated with multicentric Castleman disease successfully treated with tocilizumab].
    Nakayama H; Kikuchi T; Abe R; Tozawa K; Watanuki S; Shimizu T; Mitsuhashi T; Murata M; Okamoto S; Mori T
    Rinsho Ketsueki; 2018; 59(8):997-1001. PubMed ID: 30185717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6-positive classical Hodgkin's lymphoma co-occurring with plasma cell type of Castleman's disease: report of a case.
    Momoi A; Kojima M; Sakai T; Ajiro J; Isahai N; Nagai K; Aoki S
    Int J Hematol; 2013 Feb; 97(2):275-9. PubMed ID: 23359301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed-type multicentric Castleman's disease developing during a 17-year follow-up of sarcoidosis.
    Awano N; Inomata M; Kondoh K; Satake K; Kamiya H; Moriya A; Ando T; Kumasaka T; Takemura T; Takeuchi K; Ikushima S
    Intern Med; 2012; 51(21):3061-6. PubMed ID: 23124151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease: A case report.
    Sugawara E; Sato T; Amasaki Y; Katsumata K
    Medicine (Baltimore); 2022 Feb; 101(8):e28941. PubMed ID: 35212301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient with Castleman's disease initially manifesting symmetrical synovitis with pitting oedema.
    Kondo J; Arinuma Y; Matsueda Y; Hasegawa Y; Muramatsu T; Kanayama Y; Hoshiyama T; Tono T; Tanaka S; Oku K; Yamaoka K
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):309-313. PubMed ID: 35092673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of idiopathic multicentric Castleman disease with pulmonary hyalinizing granuloma-like multiple pulmonary nodules.
    Hatano H; Tsujimoto Y; Watanabe H; Tsukada A; Izumi S; Nagasaka S; Igari T; Suzuki M; Iikura M; Hojo M
    Respir Investig; 2023 Jul; 61(4):405-408. PubMed ID: 37099891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tocilizumab treatment of HHV8-positive/HIV-negative, multricentric plasma cell type Castleman's disease].
    Mûzes G; Csomor J; Sipos F
    Magy Onkol; 2016 Nov; 60(4):328-332. PubMed ID: 27898752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of humanized anti-interleukin-6 receptor antibody (tocilizumab) for Castleman's disease mainly with pulmonary involvement].
    Ohno N; Fujiyama S; Ooi M; Haraguchi K; Tokunaga M; Uozumi K; Tsubouchi H
    Nihon Naika Gakkai Zasshi; 2007 May; 96(5):988-90. PubMed ID: 17564092
    [No Abstract]   [Full Text] [Related]  

  • 17. Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.
    Pan Y; Cui Z; Wang S; Zheng D; Deng Z; Tian X; Guo H; Bao W; Zhou S; Wang Y
    BMC Nephrol; 2020 Dec; 21(1):528. PubMed ID: 33276741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report.
    Cai S; Zhong Z; Li X; Wang HX; Wang L; Zhang M
    Medicine (Baltimore); 2019 Nov; 98(46):e17681. PubMed ID: 31725610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbital pseudotumor as an initial manifestation of multicentric Castleman's disease.
    Inatani M; Kashii S; Nosaka K; Arima N
    Jpn J Ophthalmol; 2005; 49(6):505-508. PubMed ID: 16365797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease.
    Taniguchi K; Shimazaki C; Fujimoto Y; Shimura K; Uchiyama H; Matsumoto Y; Kuroda J; Horiike S; Taniwaki M
    Int J Hematol; 2009 Jul; 90(1):99-102. PubMed ID: 19554396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.